The recommended screening test for prostate cancer: prostate specific antigen (PSA) is mired in controversy surrounding its benefits and its ability to guide appropriate treatment options for patients with newly-diagnosed, localized prostate cancer. The gene discussed is KLK3; the disease is prostate cancer.